Obesity and diabetes related plasma amino acid alterations

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1447-1452

  Zhou, Yong ^a   Qiu, Ling ^b   Xiao, Qian ^a   Wang, Yi ^a   Meng, Xiangying ^a   Xu, Rong ^b   Wang, Siyang ^b   Na, Risu ^b  

^a Shanghai Dahua Hospital   (China)

^b Xuhui District Central Hospital   (China)

Author keywords

Amino acid concentration profiles; Diabetes; Insulin resistance; Obesity

Indexed keywords

2 AMINOBUTYRIC ACID; 3 METHYLHISTIDINE; 4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; ANSERINE; ARGININE; ARGININOSUCCINIC ACID; ASPARAGINE; ASPARTIC ACID; BETA ALANINE; CARNOSINE; CHOLESTEROL; CITRULLINE; CYSTATHIONINE; ETHANOLAMINE; GLUTAMINE; GLYCINE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTIDINE; HYDROXYLYSINE; HYDROXYPROLINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROLINE; SARCOSINE; SERINE; THREONINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

AMINO ACID CONCENTRATION PROFILES; DIABETES; INSULIN RESISTANCE; OBESITY;

AGED; AMINO ACIDS; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES;

EID: 84884355511     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.05.045     Document Type: Article

References (33)

1. Gao X., Chen W., Li R., Wang M., Chen C., Zeng R., et al. Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst Biol 2012, 6(Suppl. 1):S14.
2. Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990, 21:572-576.
3. Fleck C., Schweitzer F., Karge E., Busch M., Stein G. Serum concentrations of asymmetric (adma) and symmetric (sdma) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 2003, 336:1-12.
4. Garlichs C.D., Beyer J., Zhang H., Schmeisser A., Plotze K., Mugge A., et al. Decreased plasma concentrations of l-hydroxy-arginine as a marker of reduced no formation in patients with combined cardiovascular risk factors. J Lab Clin Med 2000, 135:419-425.
5. Valli A., Carrero J.J., Qureshi A.R., Garibotto G., Barany P., Axelsson J., et al. Elevated serum levels of s-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 2008, 395:106-110.
6. Muoio D.M., Newgard C.B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9:193-205.
7. Floyd J.C., Fajans S.S., Knopf R.F., Conn J.W. Evidence that insulin release is the mechanism for experimentally induced leucine hypoglycemia in man. J Clin Invest 1963, 42:1714-1719.
8. Kelly A., Stanley C.A. Disorders of glutamate metabolism. Ment Retard Dev Disabil Res Rev 2001, 7:287-295.
9. Newsholme P., Bender K., Kiely A., Brennan L. Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 2007, 35:1180-1186.
10. Newsholme P., Brennan L., Rubi B., Maechler P. New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond) 2005, 108:185-194.
11. Yang J., Chi Y., Burkhardt B.R., Guan Y., Wolf B.A. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev 2010, 68:270-279.
12. Dunger A., Sjoholm A., Eizirik D.L. Amino acids and human amniotic fluid increase DNA biosynthesis in pancreatic islets of adult mouse, but this effect is lost following exposure to streptozotocin. Pancreas 1990, 5:639-646.
13. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9:311-326.
14. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011, 17:448-453.
15. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 2006, 83:1237-1247.
16. Somogyi M. Determination of blood sugar. J Biol Chem 1945, 160:69-73.
17. Hales C.N., Randle P.J. Immunoassay of insulin with insulin antibody precipitate. Lancet 1963, 1:200.
18. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Wysocki V.H., Resing K.A., Zhang Q., Cheng G. Mass spectrometry of peptides and proteins. Methods 2005, 35:211-222.
20. Gibney M.J., Walsh M., Brennan L., Roche H.M., German B., van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr 2005, 82:497-503.
21. Rezzi S., Ramadan Z., Fay L.B., Kochhar S. Nutritional metabolomics: applications and perspectives. J Proteome Res 2007, 6:513-525.
22. Adeva M.M., Calvino J., Souto G., Donapetry C. Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids 2012, 43:171-181.
23. Adams S.H. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr 2011, 2:445-456.
24. Cheng S., Rhee E.P., Larson M.G., Lewis G.D., McCabe E.L., Shen D., et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2013, 125:2222-2231.
25. Kim J.Y., Park J.Y., Kim O.Y., Ham B.M., Kim H.J., Kwon D.Y., et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 2010, 9:4368-4375.
26. Hidiroglou M., Veira D.M. Plasma amino acid levels in the fat cow syndrome. Ann Rech Vet 1982, 13:111-115.
27. Verdam F.J., Greve J.W., Roosta S., van Eijk H., Bouvy N., Buurman W.A., et al. Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab 2011, 96:E379-E383.
28. Krebs M., Krssak M., Bernroider E., Anderwald C., Brehm A., Meyerspeer M., et al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 2002, 51:599-605.
29. Schwenk W.F., Haymond M.W. Decreased uptake of glucose by human forearm during infusion of leucine, isoleucine, or threonine. Diabetes 1987, 36:199-204.
30. van Loon L.J., Kruijshoop M., Menheere P.P., Wagenmakers A.J., Saris W.H., Keizer H.A. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 2003, 26:625-630.
31. +-pyrophosphatase in malaria parasites. Biochem J 2000, 347(Pt 1):243-253.
32. Solano M.P., Goldberg R.B. Management of dyslipidemia in diabetes. Cardiol Rev 2006, 14:125-135.
33. Rhee E.P., Cheng S., Larson M.G., Walford G.A., Lewis G.D., McCabe E., et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011, 121:1402-1411.